Recombinant human decorin inhibits TGF-β1-induced contraction of collagen lattice by hypertrophic scar fibroblasts

Burns

Volumn 35, Issue 4, 2009, Pages 527-537

  Zhang, Zhi ^a   Garron, Tania M ^b   Li, Xiao Jian ^a   Liu, Yan ^c   Zhang, Xiong ^c   Li, Ye Yang ^a   Xu, Wei Shi ^c  

^a JINAN UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Contraction; Decorin; Fibroblasts; Hypertrophic scar; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN GEL; DECORIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; RECOMBINANT HUMAN DECORIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; INHIBITION KINETICS; PROTEIN EXPRESSION; WOUND CONTRACTION;

ACTINS; BLOTTING, WESTERN; CELLS, CULTURED; CICATRIX, HYPERTROPHIC; COLLAGEN; CONTRACTURE; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GELS; HUMANS; MUSCLE, SMOOTH; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOGLYCANS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 63549151428     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.08.021     Document Type: Article

References (46)

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
2. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124 (1994) 401-404
3. Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R., and Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 135 (1972) 719-734
4. Brissett A.E., and Sherris D.A. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg 17 (2001) 263-272
5. Fang C.H., and Alexander J.W. Wound contraction following transplantation of microskin autografts with overlaid skin allograft in experimental animals. Burns 16 (1990) 190-192
6. Vande Berg J.S., and Rudolph R. Cultured myofibroblasts: a useful model to study wound contraction and pathological contracture. Ann Plast Surg 14 (1985) 111-120
7. Hunt T.K. Wound management and infection. J Trauma 19 (1979) 890-891
8. Redden R.A., and Doolin E.J. Collagen crosslinking and cell density have distinct effects on fibroblast-mediated contraction of collagen gels. Skin Res Technol 9 (2003) 290-293
9. Nedelec B., Ghahary A., Scott P.G., and Tredget E.E. Control of wound contraction, basic and clinical features. Hand Clin 16 (2000) 289-302
10. Rudolph R. The effect of skin graft preparation on wound contraction. Surg Gynecol Obstet 142 (1976) 49-56
11. Tredget E.E., Nedelec B., Scott P.G., and Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77 (1997) 701-730
12. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76 (1979) 1274-1278
13. Montesano R., and Orci L. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 85 (1988) 4894-4897
14. Nien Y.D., Han Y.P., Tawil B., Chan L.S., Tuan T.L., and Garner W.L. Fibrinogen inhibits fibroblast-mediated contraction of collagen. Wound Repair Regen 11 (2003) 380-385
15. Kopp J., Preis E., Said H., Hafemann B., Wickert L., Gressner A.M., et al. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 280 (2005) 21570-21576
16. Finesmith T.H., Broadley K.N., and Davidson J.M. Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors. J Cell Physiol 144 (1990) 99-107
17. Tateshita T., Ono I., and Kaneko F. Effects of collagen matrix containing transforming growth factor (TGF)-beta(1) on wound contraction. J Dermatol Sci 27 (2001) 104-113
18. Weber I.T., Harrison R.W., and Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 271 (1996) 31767-31770
19. Choi H.U., Johnson T.L., Pal S., Tang L.H., Rosenberg L., and Neame P.J. Characterization of the dermatan sulfate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by octyl-sepharose chromatography. J Biol Chem 264 (1989) 2876-2884
20. Rosenberg L.C., Choi H.U., Tang L.H., Johnson T.L., Pal S., Webber C., et al. Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem 260 (1985) 6304-6313
21. Fisher L.W., Termine J.D., Dejter Jr. S.W., Whitson S.W., Yanagishita M., Kimura J.H., et al. Proteoglycans of developing bone. J Biol Chem 258 (1983) 6588-6594
22. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-b by the proteoglycan decorin. Nature 346 (1990) 281-284
23. Border W.A., Noble N.A., Yamamoto T., Harper J.R., Yamaguchi Y., Pierschbacher M.D., et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360 (1992) 361-364
24. Isaka Y., Brees D.K., Ikegaya K., Kaneda Y., Imai E., Noble N.A., et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2 (1996) 418-423
25. Fukushima K., Badlani N., Usas A., Riano F., Fu F., and Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 29 (2001) 394-402
26. Kolb M., Margetts P.J., Sime P.J., and Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280 (2001) L1327-L1334
27. Zhang Z., Li X.J., Liu Y., Zhang X., Li Y.Y., and Xu W.S. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 33 (2007) 634-641
28. Welch M.P., Odland G.F., and Clark R.A. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110 (1990) 133-145
29. van Beurden H.E., Von den Hoff J.W., Torensma R., Maltha J.C., and Kuijpers-Jagtman A.M. Myofibroblasts in palatal wound healing: prospects for the reduction of wound contraction after cleft palate repair. J Dent Res 84 (2005) 871-880
30. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., and Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12 (2001) 2730-2741
31. Hinz B., Mastrangelo D., Iselin C.E., Chaponnier C., and Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 159 (2001) 1009-1020
32. Freyman T.M., Yannas I.V., Yokoo R., and Gibson L.J. Fibroblast contraction of a collagen-GAG matrix. Biomaterials 22 (2001) 2883-2891
33. Kutz S.M., Hordines J., McKeown-Longo P.J., and Higgins P.J. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 114 (2001) 3905-3914
34. Providence K.M., Kutz S.M., Staiano-Coico L., and Higgins P.J. PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair. J Cell Physiol 182 (2000) 269-280
35. Grinnell F., and Ho C.H. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp Cell Res 273 (2002) 248-255
36. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13 (2003) 264-269
37. Wang R., Ghahary A., Shen Q., Scott P.G., Roy K., and Tredget E.E. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 8 (2000) 128-137
38. Niessen F.B., Spauwen P.H., Schalkwijk J., and Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104 (1999) 1435-1458
39. Shah M., Foreman D.M., and Ferguson M.W. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107 (1994) 1137-1157
40. Mukhopadhyay A., Tan E.K., Khoo Y.T., Chan S.Y., Lim I.J., and Phan T.T. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices. Br J Dermatol 152 (2005) 639-645
41. Ehrlich H.P., Griswold T.R., and Rajaratnam J.B. Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin. Exp Cell Res 164 (1986) 154-162
42. Bittner K., Liszio C., Blumberg P., Schönherr E., and Kresse H. Modulation of collagen gel contraction by decorin. Biochem J 314 (1996) 159-166
43. Nakatani T., Honda E., Hayakawa S., Sato M., Satoh K., Kudo M., et al. Effects of decorin on the expression of alpha-smooth muscle actin in a human myofibroblast cell line. Mol Cell Biochem 308 (2008) 201-207
44. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3 (2002) 349-363
45. Desmoulière A., Geinoz A., Gabbiani F., and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122 (1993) 103-111
46. Harris A.K., Stopak D., and Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 290 (1981) 249-251